Listed

CareDx, Inc.

CDNANasdaqCIK 1217234HealthcareFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$139.4mRevenue, Q3 FY2026, three months to 2026-09-30$139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 29, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$139.4mRevenue, Q3 FY2026, three months to 2026-09-30$139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure+39.3% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin5.8%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure+6.1 pts on a year earlier
  • Net margin13.8%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure+12.2 pts on a year earlier
  • Diluted EPS$0.35Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure+1066.7% on a year earlier
  • Free cash flow$11.1mFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001217234-26-000061. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001217234-26-000061. Derived: 9-month figure less the 6-month figure.Report this figure−69.2% on a year earlier

Last eight quarters

Full statements
Revenue$139.4mOperating margin 5.8%
Diluted EPS$0.35, Q3 FY2026
Free cash flow$11.1m, Q3 FY2026
CareDx, Inc., key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$m86.6Revenue, Q4 FY2024, three months to 2024-12-31$86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure84.7Revenue, Q1 FY2025, three months to 2025-03-31$84.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure86.7Revenue, Q2 FY2025, three months to 2025-06-30$86.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure100Revenue, Q3 FY2025, three months to 2025-09-30$100.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure108Revenue, Q4 FY2025, three months to 2025-12-31$108.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure118Revenue, Q1 FY2026, three months to 2026-03-31$117.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure132Revenue, Q2 FY2026, three months to 2026-06-30$131.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure139Revenue, Q3 FY2026, three months to 2026-09-30$139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%97.5%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $84.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Revenue: $86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(15.8%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Revenue: $84.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure(12.8%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Revenue: $86.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure(0.2%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$246.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $100.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure(5.6%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Revenue: $108.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure1.0%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Revenue: $117.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure85.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $113.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Revenue: $131.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure5.8%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure
Net margin%101.3%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $87.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Revenue: $86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(12.2%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $84.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure(9.9%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $86.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure1.7%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $100.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure(3.8%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Revenue: $108.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure2.4%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $117.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure83.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $110.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $131.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure13.8%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Revenue: $139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)(0.19)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure(0.16)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure0.03Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figurenot reported (Diluted EPS not reported)0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure2.07Diluted EPS, Q2 FY2026, three months to 2026-06-30$2.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001217234-26-000046.Report this figure0.35Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001217234-26-000061.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)(28.2)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$26.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure8.9Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001217234-26-000046. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001217234-26-000046. Derived: 6-month figure less the 3-month figure.Report this figure36.1Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $37.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001217234-26-000061. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001217234-26-000061. Derived: 9-month figure less the 6-month figure.Report this figurenot reported (Capital expenditure not reported)0.5Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001217234-26-000033.Report this figure28.7Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $30.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001217234-26-000046. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001217234-26-000046. Derived: 6-month figure less the 3-month figure.Report this figure11.1Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001217234-26-000061. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001217234-26-000061. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$379.8mOperating margin −8.1%
Diluted EPS−$0.40, FY2025
CareDx, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m296Revenue, FY2021, twelve months to 2021-12-31$296.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001217234-24-000033.Report this figure322Revenue, FY2022, twelve months to 2022-12-31$321.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001217234-25-000012.Report this figure280Revenue, FY2023, twelve months to 2023-12-31$280.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure334Revenue, FY2024, twelve months to 2024-12-31$333.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure380Revenue, FY2025, twelve months to 2025-12-31$379.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%(10.0%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-28, accession 0001217234-24-000033.Revenue: $296.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001217234-24-000033.Report this figure(24.0%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$77.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-28, accession 0001217234-25-000012.Revenue: $321.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001217234-25-000012.Report this figure(72.5%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$203.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018.Revenue: $280.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure12.2%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $40.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018.Revenue: $333.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure(8.1%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$30.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018.Revenue: $379.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure
Net margin%(10.3%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$30.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-28, accession 0001217234-24-000033.Revenue: $296.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001217234-24-000033.Report this figure(23.8%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$76.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001217234-25-000012.Revenue: $321.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001217234-25-000012.Report this figure(67.9%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$190.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018.Revenue: $280.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure15.7%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $52.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018.Revenue: $333.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure(5.6%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001217234-26-000018.Revenue: $379.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure
Diluted EPS$ per share(0.59)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-28, accession 0001217234-24-000033.Report this figure(1.44)Diluted EPS, FY2022, twelve months to 2022-12-31−$1.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-28, accession 0001217234-25-000012.Report this figure(3.54)Diluted EPS, FY2023, twelve months to 2023-12-31−$3.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure0.93Diluted EPS, FY2024, twelve months to 2024-12-31$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure(0.40)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001217234-26-000018.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding CareDx, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$137.2m4,814,709Added+292,613
STATE STREET CORP2026-06-30$70.4m2,468,858Reduced−291,527
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$62.6m2,197,475Added+37,018
DEERFIELD MANAGEMENT COMPANY, L.P.2026-06-30$56.9m1,997,618Reduced−193,382
ARK Investment Management LLC2026-06-30$55.7m1,953,531Reduced−274,025
Boston Partners2026-06-30$55.2m1,937,601Added+54,067
BAMCO INC /NY/2026-06-30$55.2m1,937,326Reduced−1,399,083
GAGNON SECURITIES LLC2026-06-30$50.5m1,770,735Added+8,861
Chevy Chase Trust Holdings, LLC2026-06-30$41.0m1,437,416Reduced−66,659
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$37.9m1,328,037Added+73,923

Recent filings

All 1,378 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

CareDx, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2916:04 ET10-QQuarterly reportPeriod 2026-09-300001217234-26-000061
2026-10-2916:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001217234-26-000059
2026-09-1616:06 ET8-K/A2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001217234-26-000052
2026-07-3016:04 ET10-QQuarterly reportPeriod 2026-06-300001217234-26-000046
2026-07-3016:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001217234-26-000045
2026-07-0717:12 ET8-K2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001217234-26-000038
2026-06-1516:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001217234-26-000036
2026-04-2816:13 ET10-QQuarterly reportPeriod 2026-03-310001217234-26-000033
2026-04-2816:05 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-050317
2026-04-2716:06 ETDEF 14AProxy statementPeriod 2026-04-270001217234-26-000028

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures.See the target

About the filer

CIK
1217234
Tickers
CDNA
Exchange
Nasdaq
SIC code
8071 Services-Medical Laboratories
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
XDx, Inc. (to 2011-11-15); EXPRESSION DIAGNOSTICS INC (to 2005-12-14)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:39 ET. Listed shows no prices and gives no investment advice.